Discontinued — last reported Q4 '25
Software and Technology Licenses, Net
Revolution Medicines, Inc. Software and Technology Licenses, Net decreased by 2.0% to $14.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $13.13M to $14.48M. Over 5 years (FY 2020 to FY 2025), Software and Technology Licenses, Net shows an upward trend with a 117.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests ongoing investment in technology and digital capabilities, which can drive long-term operational efficiency.
Detailed definition
This represents the capitalized cost of acquired software and technology licenses, net of accumulated amortization. It r...
Peer comparison
Increasingly important across the restaurant sector as companies invest in mobile apps, kiosks, and data analytics.
software_technology_licenses_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $264.00K | $264.00K | $758.00K | $851.00K | $725.00K | $856.00K | $2.86M | $2.77M | $2.69M | $11.35M | $7.03M | $4.16M | $8.27M | $10.28M | $1.74M | $13.13M | $31.42M | $14.87M | $14.78M | $14.48M |
| QoQ Change | — | +0.0% | +187.1% | +12.3% | -14.8% | +18.1% | +233.8% | -3.0% | -2.9% | +321.9% | -38.1% | -40.9% | +98.9% | +24.2% | -83.0% | +653.8% | +139.3% | -52.7% | -0.6% | -2.0% |
| YoY Change | — | — | — | — | +174.6% | +224.2% | +276.9% | +225.7% | +271.2% | >999% | +146.1% | +50.0% | +207.5% | -9.5% | -75.2% | +215.7% | +279.7% | +44.7% | +748.4% | +10.3% |
Software and Technology Licenses, Net at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s software and technology licenses, net?
- Revolution Medicines, Inc. (RVMD) reported software and technology licenses, net of $14.48M in Q1 2026.
- How has Revolution Medicines, Inc.'s software and technology licenses, net changed year-over-year?
- Revolution Medicines, Inc.'s software and technology licenses, net increased by 10.3% year-over-year, from $13.13M to $14.48M.
- What is the long-term trend for Revolution Medicines, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s software and technology licenses, net has grown at a 117.3% compound annual growth rate (CAGR), from $305.00K to $14.78M.
- What does software and technology licenses, net mean?
- The net book value of the company's software and technology licenses.